Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

34.18
Delayed Data
As of 4:01pm ET
 +0.64 / +1.91%
Today’s Change
30.89
Today|||52-Week Range
57.81
-4.68%
Year-to-Date
NVO Regular Dividend: NVO began trading ex-dividend on 03/23/17. A $0.6633 dividend will be paid to shareholders of record as of 03/27/17.
No recent news for Novo Nordisk.

Today’s Trading

Previous close33.54
Today’s open33.90
Day’s range33.77 - 34.28
Volume1,708,739
Average volume (3 months)2,872,200
Market cap$65.8B
Dividend yield3.88%
Data as of 4:01pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+3.81%
P/E ratio2.3
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.03-0.07%
SHPGShire+2.93+1.67%
AZNAstraZeneca+0.49+1.56%
AGNAllergan+2.05+0.86%
Data as of 4:01pm ET, 03/27/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.53
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Chief Financial Officer &
Executive Vice President
Jesper Brandgaard
Corporate headquarters
Bagsværd, Capital Region

Forecasts


Search for Jobs